Prolonged deferral of antiretroviral therapy in the SAPIT trial: did we need a clinical trial to tell us that this would increase mortality?

S Afr Med J. 2010 Sep 7;100(9):566, 568, 570-1. doi: 10.7196/samj.4434.
No abstract available

MeSH terms

  • AIDS-Related Opportunistic Infections / microbiology
  • Anti-Bacterial Agents / therapeutic use*
  • Anti-Retroviral Agents / administration & dosage*
  • CD4 Lymphocyte Count
  • Clinical Trials as Topic / ethics*
  • Drug Administration Schedule
  • HIV Infections / drug therapy*
  • HIV Infections / mortality*
  • Humans
  • Immune Reconstitution Inflammatory Syndrome
  • South Africa / epidemiology
  • Therapeutic Equipoise
  • Tuberculosis / drug therapy*
  • Tuberculosis / mortality

Substances

  • Anti-Bacterial Agents
  • Anti-Retroviral Agents